PsyLabs
Tracked across 1 events · 6 articles · First seen Sep 14, 2026 · Last active Sep 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Psyence Biomedical Ltd. (Nasdaq: PBM) announced on September 14, 2026 the formation of Texas Ibogaine Research Corporation (TIRC), a Texas-based company established to coordinate the Company's U.S. ibogaine development activities, including pharmaceutical-grade supply, regulatory engagement…
Impact: PsyLabs is the neuroplastogen API developer whose pharmaceutical-grade ibogaine would be licensed to TIRC. The arrangement could expand PsyLabs' U.S. distribution and regulatory footprint if definitive licensing is completed.
Sep 14, 2026 · 6 articles
60
Psyence Biomedical positioned to hold rights PsyLabsPsyence BioMed Forms Texas...
ERGEN INTELLIGENCE
Track PsyLabs live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard